1-amino-2,3,7,8-tetrachlorodibenzo-p-dioxin

Suppliers

Names

[ CAS No. ]:
62782-13-2

[ Name ]:
1-amino-2,3,7,8-tetrachlorodibenzo-p-dioxin

[Synonym ]:
DIBENZO-p-DIOXIN,1-AMINO-2,3,7,8-TETRACHLORO
1-Amino-2,3,7,8-tetrachlorodibenzo-p-dioxin

Chemical & Physical Properties

[ Density]:
1.699g/cm3

[ Boiling Point ]:
464.1ºC at 760 mmHg

[ Molecular Formula ]:
C12H5Cl4NO2

[ Molecular Weight ]:
336.98600

[ Flash Point ]:
234.5ºC

[ Exact Mass ]:
334.90700

[ PSA ]:
44.48000

[ LogP ]:
6.36160

[ Index of Refraction ]:
1.695

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
HP3095000
CHEMICAL NAME :
Dibenzo-p-dioxin, 1-amino-2,3,7,8-tetrachloro-
CAS REGISTRY NUMBER :
62782-13-2
LAST UPDATED :
199303
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C12-H5-Cl4-N-O2
MOLECULAR WEIGHT :
336.98
WISWESSER LINE NOTATION :
T C666 BO IOJ DZ EG FG LG MG

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>4800 ug/kg
TOXIC EFFECTS :
Endocrine - changes in spleen weight Endocrine - changes in thymus weight Blood - changes in serum composition (e.g. TP, bilirubin, cholesterol)
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 44,335,1978
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - guinea pig
DOSE/DURATION :
>194 ug/kg
TOXIC EFFECTS :
Endocrine - changes in thymus weight
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 44,335,1978

Related Compounds

  • 1-Nitro-2,3,7,8-tetrachlorodibenzo-p-dioxin
  • 1-bromo-2,3,7,8-tetrachlorodibenzo-p-dioxin
  • 1,3,7,8-Tetrachlorodibenzo-p-dioxin
  • 2,3,7,8-tetrachlorodibenzo-p-dioxin-1-ol
  • C-132,3,7,8-TCDD
  • 1,2,3,7,8,9-Hexachlorodibenzo-p-dioxin
  • [(2,3-Dihydro-1,4-benzodioxin-6-yl)methyl](methyl)(1-phenylethyl)amine
  • 3-({6-Phenyl-2-azaspiro[3.3]heptan-2-yl}methyl)benzonitrile
  • 1-{4-[(1-{3-Methyl-[1,2,4]triazolo[4,3-a]pyrazin-8-yl}piperidin-4-yl)oxy]but-2-yn-1-yl}-4-phenylpiperazine
  • 3-(3,5-dimethyl-1H-pyrazol-1-yl)-6-(4-{thieno[3,2-c]pyridin-4-yl}piperazin-1-yl)pyridazine
  • [(3,4-Difluorophenyl)methyl][(2,3-dihydro-1,4-benzodioxin-6-yl)methyl]methylamine
  • 4-(3,5-dimethyl-1H-pyrazol-1-yl)-6-(4-{thieno[3,2-c]pyridin-4-yl}piperazin-1-yl)pyrimidine
  • [(3,5-Difluorophenyl)methyl][(2,3-dihydro-1,4-benzodioxin-6-yl)methyl]methylamine
  • 4-(3,5-dimethyl-1H-pyrazol-1-yl)-2-methyl-6-(4-{2-methylpyrido[3,4-d]pyrimidin-4-yl}piperazin-1-yl)pyrimidine
  • 2-{4-[6-(1H-pyrazol-1-yl)pyridazin-3-yl]piperazin-1-yl}-1,3-benzothiazole
  • 6-{4-[6-(1H-pyrazol-1-yl)pyridazin-3-yl]piperazin-1-yl}-9H-purine
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.